UY33176A - Derivados de oxazolopirimidina sustituida en 2, 5, 7. - Google Patents

Derivados de oxazolopirimidina sustituida en 2, 5, 7.

Info

Publication number
UY33176A
UY33176A UY0001033176A UY33176A UY33176A UY 33176 A UY33176 A UY 33176A UY 0001033176 A UY0001033176 A UY 0001033176A UY 33176 A UY33176 A UY 33176A UY 33176 A UY33176 A UY 33176A
Authority
UY
Uruguay
Prior art keywords
oxazolopirimidine
derivatives
replaced
formula
compounds
Prior art date
Application number
UY0001033176A
Other languages
English (en)
Inventor
Dr Axel Dietrich
Dr Andreas Gille
Dr Stephanie Hachtel
Dr Katrin Hiss
Dr Thomas Huebschle
Dr Dieter Kadereit
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY33176A publication Critical patent/UY33176A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de oxazolopirimidina de la fórmula I, en la que A, R1, R2 y R3 se definen como se ha indicado en las reivindicaciones. Los compuestos de la fórmula I son adecuados, por ejemplo, para la cicatrización de las heridas.
UY0001033176A 2010-01-13 2011-01-11 Derivados de oxazolopirimidina sustituida en 2, 5, 7. UY33176A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10305035 2010-01-13

Publications (1)

Publication Number Publication Date
UY33176A true UY33176A (es) 2011-08-31

Family

ID=41820512

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033176A UY33176A (es) 2010-01-13 2011-01-11 Derivados de oxazolopirimidina sustituida en 2, 5, 7.

Country Status (21)

Country Link
US (1) US8785439B2 (es)
EP (1) EP2523961B1 (es)
JP (1) JP5844276B2 (es)
KR (1) KR101759126B1 (es)
CN (1) CN102791716B (es)
AR (1) AR079980A1 (es)
AU (1) AU2011206611B2 (es)
BR (1) BR112012017393A2 (es)
CA (1) CA2791445C (es)
DK (1) DK2523961T3 (es)
ES (1) ES2448645T3 (es)
HK (1) HK1178884A1 (es)
IL (1) IL220707A (es)
MX (1) MX2012007835A (es)
MY (1) MY156525A (es)
PT (1) PT2523961E (es)
RU (1) RU2557246C2 (es)
SG (1) SG183101A1 (es)
TW (1) TWI485153B (es)
UY (1) UY33176A (es)
WO (1) WO2011086075A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011206615B2 (en) * 2010-01-14 2015-03-19 Sanofi Carboxylic acid derivatives having A 2,5-substituted oxazolopyrimidine ring
CN102834399B (zh) * 2010-01-14 2015-04-22 赛诺菲 具有2,5-取代的*唑并嘧啶环的杂环羧酸衍生物
MY159857A (en) 2010-01-14 2017-02-15 Sanofi Sa 2,5-substituted oxazolopyrimidine derivatives
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring
CN108289867A (zh) 2015-07-02 2018-07-17 地平线孤儿病有限责任公司 Ado-抗性的半胱胺类似物和其用途
JP7429799B2 (ja) 2020-02-18 2024-02-08 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
TW202322824A (zh) 2020-02-18 2023-06-16 美商基利科學股份有限公司 抗病毒化合物
EP4323362A1 (en) 2021-04-16 2024-02-21 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
US12116380B2 (en) 2021-08-18 2024-10-15 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2523739A1 (en) 2003-04-25 2004-11-11 University College Cardiff Consultants Limited Heterocyclic compounds for use in the treatment of viral infections
PE20050158A1 (es) * 2003-05-19 2005-05-12 Irm Llc Compuestos inmunosupresores y composiciones
FR2865208B1 (fr) * 2004-01-16 2009-01-16 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique
US7855193B2 (en) * 2005-11-23 2010-12-21 Epix Pharmaceuticals, Inc. S1P receptor modulating compounds and use thereof
WO2007109334A2 (en) * 2006-03-21 2007-09-27 Epix Delaware, Inc. Sip receptor modulating compounds and use thereof
EP1900729A1 (en) * 2006-09-15 2008-03-19 Novartis AG Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
EP2318415B1 (en) 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
TWI517851B (zh) 2010-01-13 2016-01-21 賽諾菲阿凡提斯公司 含２，５，７－經取代唑并嘧啶環之雜環羧酸衍生物
AR079981A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido
CN102834399B (zh) 2010-01-14 2015-04-22 赛诺菲 具有2,5-取代的*唑并嘧啶环的杂环羧酸衍生物
AU2011206615B2 (en) 2010-01-14 2015-03-19 Sanofi Carboxylic acid derivatives having A 2,5-substituted oxazolopyrimidine ring
MY159857A (en) 2010-01-14 2017-02-15 Sanofi Sa 2,5-substituted oxazolopyrimidine derivatives

Also Published As

Publication number Publication date
RU2557246C2 (ru) 2015-07-20
TW201141873A (en) 2011-12-01
KR20120115544A (ko) 2012-10-18
US8785439B2 (en) 2014-07-22
BR112012017393A2 (pt) 2017-12-12
IL220707A0 (en) 2012-08-30
CA2791445A1 (en) 2011-07-21
CN102791716A (zh) 2012-11-21
MY156525A (en) 2016-02-26
EP2523961B1 (de) 2013-12-18
JP5844276B2 (ja) 2016-01-13
AR079980A1 (es) 2012-03-07
WO2011086075A1 (de) 2011-07-21
CA2791445C (en) 2017-08-29
PT2523961E (pt) 2014-03-20
EP2523961A1 (de) 2012-11-21
DK2523961T3 (en) 2014-03-24
RU2012134349A (ru) 2014-02-20
CN102791716B (zh) 2016-05-11
ES2448645T3 (es) 2014-03-14
IL220707A (en) 2015-02-26
SG183101A1 (en) 2012-09-27
KR101759126B1 (ko) 2017-07-18
US20130137685A1 (en) 2013-05-30
AU2011206611A1 (en) 2012-08-02
JP2013517238A (ja) 2013-05-16
AU2011206611B2 (en) 2015-03-05
MX2012007835A (es) 2012-07-30
TWI485153B (zh) 2015-05-21
HK1178884A1 (es) 2013-09-19

Similar Documents

Publication Publication Date Title
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
UY33199A (es) 5-alquinil-pirimidinas.
CO6450612A2 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
CR20140091A (es) Nuevos derivados dihidroquinolina-2-ona
ECSP11011244A (es) Nuevos herbicidas.
UY32799A (es) Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos
CR20140079A (es) Aminoquinazolinas como inhibidores de quinasa
UY32553A (es) Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
HN2011001999A (es) Herbicidas derivados de ciclopentanodiona
ECSP11011245A (es) Novedosos herbicidas
ECSP11010816A (es) Nuevos Compuestos
CU20110220A7 (es) Espiro-epóxidos como productos intermedios
UY33179A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2,5-sustituido.
UY33180A (es) Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.
UY33177A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.
ECSP11011454A (es) 5-alquinil-piridinas
CR20150272A (es) Derivado de hidantoina
UY33092A (es) Compuestos de triazol, su uso y agentes que los contienen
UY32101A (es) Compuestos de triazol, su uso, así como productos que los contienen
UY32103A (es) Compuestos de triazol, su uso, así como productos que los contienen
UY32102A (es) Compuestos de triazol, su uso, así como productos que los contienen

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140610